Literature DB >> 18983824

Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulation.

Yosuke Ikegami1, Hidemasa Goto, Tohru Kiyono, Masato Enomoto, Kousuke Kasahara, Yasuko Tomono, Keiichi Tozawa, Akimichi Morita, Kenjiro Kohri, Masaki Inagaki.   

Abstract

We previously reported Chk1 to be phosphorylated at Ser286 and Ser301 by cyclin-dependent kinase (Cdk) 1 during mitosis [T. Shiromizu et al., Genes Cells 11 (2006) 477-485]. Here, we demonstrated that Chk1-Ser286 and -Ser301 phosphorylation also occurs in hydroxyurea (HU)-treated or ultraviolet (UV)-irradiated cells. Unlike the mitosis case, however, Chk1 was phosphorylated not only at Ser286 and Ser301 but also at Ser317 and Ser345 in the checkpoint response. Treatment with Cdk inhibitors diminished Chk1 phosphorylation at Ser286 and Ser301 but not at Ser317 and Ser345 with the latter. In vitro analyses revealed Ser286 and Ser301 on Chk1 to serve as two major phosphorylation sites for Cdk2. Immunoprecipitation analyses further demonstrated that Ser286/Ser301 and Ser317/Ser345 phosphorylation occur in the same Chk1 molecule during the checkpoint response. In addition, Ser286/Ser301 phosphorylation by Cdk2 was observed in Chk1 mutated to Ala at Ser317 and Ser345 (S317A/S345A), as well as Ser317/Ser345 phosphorylation by ATR was in S286A/S301A. Therefore, Chk1 phosphorylation in the checkpoint response is regulated not only by ATR but also by Cdk2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983824     DOI: 10.1016/j.bbrc.2008.10.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.

Authors:  Masato Enomoto; Hidemasa Goto; Yasuko Tomono; Kousuke Kasahara; Kunio Tsujimura; Tohru Kiyono; Masaki Inagaki
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

2.  14-3-3gamma mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage.

Authors:  Kousuke Kasahara; Hidemasa Goto; Masato Enomoto; Yasuko Tomono; Tohru Kiyono; Masaki Inagaki
Journal:  EMBO J       Date:  2010-07-16       Impact factor: 11.598

3.  Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Authors:  Vanessa Oakes; Weili Wang; Brittney Harrington; Won Jae Lee; Heather Beamish; Kee Ming Chia; Alex Pinder; Hidemasa Goto; Masaki Inagaki; Sandra Pavey; Brian Gabrielli
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.

Authors:  Ping Li; Hidemasa Goto; Kousuke Kasahara; Makoto Matsuyama; Zhonghua Wang; Yasushi Yatabe; Tohru Kiyono; Masaki Inagaki
Journal:  Mol Biol Cell       Date:  2012-02-22       Impact factor: 4.138

5.  Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo.

Authors:  Ryan Montano; Ruth Thompson; Injae Chung; Huagang Hou; Nadeem Khan; Alan Eastman
Journal:  BMC Cancer       Date:  2013-12-21       Impact factor: 4.430

6.  The kinase domain residue serine 173 of Schizosaccharomyces pombe Chk1 kinase is critical for the response to DNA replication stress.

Authors:  Naomi Coulton; Thomas Caspari
Journal:  Biol Open       Date:  2017-12-15       Impact factor: 2.422

7.  Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.

Authors:  Kai Liu; Minying Zheng; Qi Zhao; Kexin Zhang; Zugui Li; Fangmei Fu; Hao Zhang; Jiaxing Du; Yuwei Li; Shiwu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.